The University of Southampton
University of Southampton Institutional Repository

Personalising device therapy by redefining the sensing mechanism of the subcutaneous implantable cardioverter defibrillator

Personalising device therapy by redefining the sensing mechanism of the subcutaneous implantable cardioverter defibrillator
Personalising device therapy by redefining the sensing mechanism of the subcutaneous implantable cardioverter defibrillator
Ventricular tachyarrhythmias (VTA) are rapid abnormal heart rhythms which can result in haemodynamic compromise, collapse and sudden cardiac death (SCD). The annual global mortality burden attributed to VTA is approximately 6 million. Fortunately, in populations at high risk of arrhythmic death, the implantable cardioverter defibrillator (ICD) significantly reduces mortality and is superior to medical therapy in both the primary and secondary prevention of SCD.

The subcutaneous ICD (S‐ICD) represents a new approach in defibrillator therapy. Utilising an entirely avascular location, the S‐ICD can diagnose and treat VTA, whilst avoiding the significant complications that have traditionally been associated with transvenous defibrillator leads. Accurate rhythm detection remains vital and increasingly sophisticated diagnostic algorithms are utilised. Life‐saving therapy must never be incorrectly withheld, but inappropriate shocks, which are themselves associated with increased mortality and psychological morbidity, must also be minimised.

The S‐ICD senses electrocardiogram (ECG) signals from a standardised subcutaneous location at which effective defibrillation has been consistently demonstrated. Three different sensing vectors are available of which one is selected for clinical use. Rhythm detection requires certain morphological ECG characteristics to be present in the selected vector and pre‐implant ECG screening is therefore a mandatory requirement.
The commonest cause for vector screening failure is the presence of a low R:T ratio, as this prevents the S‐ICD from easily distinguishing R wave signal (ventricular depolarisation) from T wave signal (ventricular repolarisation). The overall axes of ventricular depolarisation and repolarisation are unique to an individual. R and T wave amplitudes are therefore determined, in part, by the angle from which they are observed.
Mathematical vector rotation is a novel strategy which can manipulate the angle of observation of an individual’s ECG, using data recorded from the current S‐ICD location.
This can produce personalised vectors; unique individualised vectors with a recipient’s maximal R:T ratio.

In this thesis, I will describe how personalised vector generation can be achieved, before applying the technique to a cohort of S‐ICD ineligible patients. Significant improvements in R:T ratio and device eligibility will be demonstrated. I will then explore the broader impact of vector rotation on the current rhythm discrimination properties of the S‐ICD system. I will demonstrate that both ventricular fibrillation detection and supraventricular
tachycardia discrimination are not impaired by vector rotation. These are key principles of S‐ICD sensing which must be maintained by any future sensing strategy.

Finally, I shall consider the phenomena of T wave over‐sensing (TWOS), which despite the current screening process, remains the commonest cause of inappropriate shock therapy in the S‐ICD population. I will describe a new concept, ‘eligible vector time’, and demonstrate experimentally that patients experience chronological fluctuations in their device eligibility. This preliminary work will redefine our current understanding of device eligibility and justify future research into the role of vector rotation in reducing inappropriate shock therapies.

In summary, I believe that clinicians and patients should not be restricted by the inherent limitations of standardised vector selection. Personalised vector generation can be achieved from the current S‐ICD location, whilst maintaining the excellent rhythm detection qualities of the S‐ICD system. Increased S‐ICD eligibility can be achieved and the potential to reduce TWOS in the future cannot be ignored.
University of Southampton
Wiles, Benedict Mark
a42ba978-24c3-4533-8eca-498102004477
Wiles, Benedict Mark
a42ba978-24c3-4533-8eca-498102004477
Morgan, John
7bd04ada-ca61-4a2c-b1cf-1750ffa9d89c
Roberts, Paul R.
193431e8-f9d5-48d6-8f62-ed9052b2571d

Wiles, Benedict Mark (2019) Personalising device therapy by redefining the sensing mechanism of the subcutaneous implantable cardioverter defibrillator. Doctoral Thesis, 154pp.

Record type: Thesis (Doctoral)

Abstract

Ventricular tachyarrhythmias (VTA) are rapid abnormal heart rhythms which can result in haemodynamic compromise, collapse and sudden cardiac death (SCD). The annual global mortality burden attributed to VTA is approximately 6 million. Fortunately, in populations at high risk of arrhythmic death, the implantable cardioverter defibrillator (ICD) significantly reduces mortality and is superior to medical therapy in both the primary and secondary prevention of SCD.

The subcutaneous ICD (S‐ICD) represents a new approach in defibrillator therapy. Utilising an entirely avascular location, the S‐ICD can diagnose and treat VTA, whilst avoiding the significant complications that have traditionally been associated with transvenous defibrillator leads. Accurate rhythm detection remains vital and increasingly sophisticated diagnostic algorithms are utilised. Life‐saving therapy must never be incorrectly withheld, but inappropriate shocks, which are themselves associated with increased mortality and psychological morbidity, must also be minimised.

The S‐ICD senses electrocardiogram (ECG) signals from a standardised subcutaneous location at which effective defibrillation has been consistently demonstrated. Three different sensing vectors are available of which one is selected for clinical use. Rhythm detection requires certain morphological ECG characteristics to be present in the selected vector and pre‐implant ECG screening is therefore a mandatory requirement.
The commonest cause for vector screening failure is the presence of a low R:T ratio, as this prevents the S‐ICD from easily distinguishing R wave signal (ventricular depolarisation) from T wave signal (ventricular repolarisation). The overall axes of ventricular depolarisation and repolarisation are unique to an individual. R and T wave amplitudes are therefore determined, in part, by the angle from which they are observed.
Mathematical vector rotation is a novel strategy which can manipulate the angle of observation of an individual’s ECG, using data recorded from the current S‐ICD location.
This can produce personalised vectors; unique individualised vectors with a recipient’s maximal R:T ratio.

In this thesis, I will describe how personalised vector generation can be achieved, before applying the technique to a cohort of S‐ICD ineligible patients. Significant improvements in R:T ratio and device eligibility will be demonstrated. I will then explore the broader impact of vector rotation on the current rhythm discrimination properties of the S‐ICD system. I will demonstrate that both ventricular fibrillation detection and supraventricular
tachycardia discrimination are not impaired by vector rotation. These are key principles of S‐ICD sensing which must be maintained by any future sensing strategy.

Finally, I shall consider the phenomena of T wave over‐sensing (TWOS), which despite the current screening process, remains the commonest cause of inappropriate shock therapy in the S‐ICD population. I will describe a new concept, ‘eligible vector time’, and demonstrate experimentally that patients experience chronological fluctuations in their device eligibility. This preliminary work will redefine our current understanding of device eligibility and justify future research into the role of vector rotation in reducing inappropriate shock therapies.

In summary, I believe that clinicians and patients should not be restricted by the inherent limitations of standardised vector selection. Personalised vector generation can be achieved from the current S‐ICD location, whilst maintaining the excellent rhythm detection qualities of the S‐ICD system. Increased S‐ICD eligibility can be achieved and the potential to reduce TWOS in the future cannot be ignored.

Text
Personalising Device Therapy by Redefining the Sensing Mechanism of the Subcutaneous Implantable Cardioverter Defibrillator - Version of Record
Available under License University of Southampton Thesis Licence.
Download (2MB)
Text
Permission to deposit thesis form
Restricted to Repository staff only
Available under License University of Southampton Thesis Licence.
Text
Declaration of authorship
Restricted to Repository staff only
Available under License University of Southampton Thesis Licence.

More information

Published date: May 2019

Identifiers

Local EPrints ID: 449003
URI: http://eprints.soton.ac.uk/id/eprint/449003
PURE UUID: f4e38151-4692-45be-a857-e7118ecad8b5

Catalogue record

Date deposited: 13 May 2021 16:38
Last modified: 16 Mar 2024 12:16

Export record

Contributors

Author: Benedict Mark Wiles
Thesis advisor: John Morgan
Thesis advisor: Paul R. Roberts

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×